Patents by Inventor Maarten Dewilde

Maarten Dewilde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides inhibiting CD40L
    Patent number: 11248055
    Abstract: The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.
    Type: Grant
    Filed: November 28, 2016
    Date of Patent: February 15, 2022
    Assignee: Ablynx N.V.
    Inventors: Els Pattyn, Ariëlla Van de Sompel, Peter Meerts, Marie-Ange Buyse, Maarten Dewilde, Gerald Beste, Jaromir Vlach, Jonathan Hsu
  • POLYPEPTIDES INHIBITING CD40L
    Publication number: 20180355050
    Abstract: The present invention relates to immunoglobulins that specifically bind CD40L and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of CD40L and are safe.
    Type: Application
    Filed: November 28, 2016
    Publication date: December 13, 2018
    Applicant: Ablynx N.V.
    Inventors: Els Pattyn, Ariëlla Van de Sompel, Peter Meerts, Marie-Ange Buyse, Maarten Dewilde, Gerald Beste, Jaromir Vlach, Jonathan Hsu
  • IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM
    Publication number: 20110117113
    Abstract: The invention relates to immunoglobulin single variable domains directed against specific human CXCR4 epitopes (herein also referred to interchangeably as “compounds of the invention”, “amino acid sequences of the invention”, or “building blocks of the invention”) and polypeptides comprising them (herein also referred to as “polypeptides of the invention”, “compounds of the invention”, or “constructs of the invention”).
    Type: Application
    Filed: October 4, 2010
    Publication date: May 19, 2011
    Inventors: Gerald Beste, Stephanie Staelens, Peter Vanlandschoot, Maria Gonzalez Pajuelo, Hilde Adi Pierrette Revets, Peter Schotte, Hilde Stals, Ann Brige, Maarten Dewilde, Catelijne Stortelers